Features of in-hospital clinical course of pulmonary embolism in patients of different age groups

Aim. To study the clinical course and management of patients with pulmonary embolism (PE) of various age groups hospitalized in a cardiology hospital.

Material and methods. This prospective single-center study in the period from 2016 to 2018 included 154 patients with PE verified by computed tomography. Statistical processing was conducted using the MedCalcVersion 16.2.1 software package (Softwa, Belgium).

Results. In all groups, female patients dominated, but the highest number of women (70,7%) belonged to the group of senile patients, while in the group <60 years, only half of patients with PE were women. Comorbid cardiovascular disease and deep vein thrombosis was diagnosed in eldest patients significantly more often than in those <60 years of age. The highest prevalence of cancer and recurrent PE were identified in the group of elderly patients. Thrombolytic therapy was performed most often in patients 60-75 years old, since these patients had a high risk of 30-day mortality according to Pulmonary Embolism Severity Index, but did not have severe comorbidities, as patients older than 75 years. An increase of right atrium size was found in the group of elderly and senile patients in comparison with patients <60 years. The highest pulmonary artery systolic and diastolic pressure was observed in the patients older than 75 years.

Conclusion. In the Kemerovo Oblast, PE most often develops in patients aged 60-75 years and is characterized by a more severe clinical course compared with patients younger than 60 years. Patients over the 60 years of age have severe cardiovascular comorbidity status, atrial fibrillation/flutter and recurrent PE. Surgical treatment for senile patients is limited due to the high risk of postoperative complications, which specifies high mortality. Patients <60 years of age are a third of all patients hospitalized with PE. They have a low risk of mortality, but have an unfavorable course of the hospital period.

1. Konstantinides SV, Torbicki A, Agnelli G, et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014;35(43):3033-69, 3069a-3069k. doi:10.1093/eurheartj/ehu283.

2. Ermolaev M, Plavunov NF, Spiridonova EA, et al. Pulmonary thromboembolism: medical-demographic characteristics, pathophysiological features of acute period, risk factors. Tromboz, Gemostaz i Reologia. 2011;(2):25-33. (In Russ.)

3. Chechulova AV, Kapustin SI, Soldatenkov VE, et al. Gene polymorphism of tissue plasminogen activator and risk of recurrent venous thromboembolism in young patients. Tromboz, Gemostaz i Reologia. 2018;4:10-5. (In Russ.) doi: 10.25555/THR.2018.4.0857.

4. Petelina IY, Zelentsova YV, Irimia RN. Analysis of patients with pulmonary embolism. Sustainable development of science and education. 2018;(5): 128-31. (In Russ.)

5. Puurunen MK, Gona PN, Larson MG, et al. Epidemiology of venous thromboembolism in the Framingham Heart Study. Thromb Res. 2016;145:27-33. doi:10.1016/j.thromres.2016.06.033.

6. Inurrieta A, Pedrajas JM, Nunez MJ, et al. RIETE Investigators. Outcomes beyond the Third Month of Anticoagulation in Patients Aged >75 Years with a First Episode of Unprovoked Venous Thromboembolism. TH Open. 2018;2(4):e428-e436. doi:10.1055/s-0038-1676359.

7. Kempny A, Mc Cabe C, Dimopoulos K, et al. Incidence, mortality and bleeding rates associated with pulmonary embolism in England between 1997 and 2015. Int J Cardiol. 2019;277:229-34. doi:10.1016/j.ijcard.2018.10.001.

8. Oliea V, Fuhrmana C, Chin F, et al. Time trends in pulmonary embolism mortality in France, 2000-2010. Thromb Res. 2015;135(2):334-8. doi:10.1016/j.thromres.2014.12.002.

9. Barco S, Mahmoudpour SH, Planquette B, et al. Prognostic value of right ventricular dysfunction or elevated cardiac biomarkers in patients with low-risk pulmonary embolism: a systematic review and metaanalysis. Eur Heart J. 2019;40(11):902-10. doi:10.1093/eurheartj/ehy873.

10. Medvedev AP, Deryabin RA, Chiginev VA, et al. Tactical features and results of pulmonary artery deobliteration in elderly and senile patients. Medicinskij al’manah. 2017;3(48):69-72. (In Russ.)

11. Demir B, Oguzturk H, Turtay MG. Pulmonary embolism: single and multiple risk factors. Biomed Res. 2017;28(9):4213-8.

12. Gjonbrataj E, Kim JN, Gjonbrataj J, et al. Risk factors associated with provoked pulmonary embolism. Korean J Intern Med. 2017;32(1):95-101. doi:10.3904/kjim.2015.118.

13. Keller K, Beule J, Coldewey M, et al. The risk factor age in normotensive patients with pulmonary embolism: Effectiveness of age in predicting submassive pulmonary embolism, cardiac injury, right ventricular dysfunction and elevated systolic pulmonary artery pressure in normotensive pulmonary embolism patients. Exp Gerontol. 2015;69:116-21. doi:10.1016/j.exger.2015.05.007.

14. Vasil’tseva OYa, Vorozhtsova IN, Kristinin AV, et al. Thromboembolism of pulmonary artery branches based on the registry data of Tomsk hospitals. Clinical Medicine (Russian Journal). 2013;(3):28-30. (In Russ.)

15. Kladov SYu. The structure of mortality of the population in the Tomsk region and possible ways to reduce it. Kazanskij medicinskij zhurnal. 2011;92(1):91-3. (In Russ.)

16. Fesenko OV, Sinopal’nikov AI, Glechikov AV. Analysis of fatal outcomes from pulmonary thromboembolism in young subjects. Therapeutic Archive. 2013;85(3):44-50. (In Russ.)

17. 17 Spirk D, Husmann M, Hayoz D, et al. Predictors of in-hospital mortality in elderly patients with acute venous thrombo-embolism: the SWIss Venous Thrombo Embolism Registry (SWIVTER). Eur Heart J. 2012;33(7):921-6. doi:10.1093/eurheartj/ehr392.

18. Watanabe N, Fettich J, Kucuk NO, et al. Modified PISAPED Criteria in Combination with Ventilation Scintigraphic Finding for Predicting Acute Pulmonary Embolism. World J Nucl Med. 2015;14(3):178-83. doi:10.4103/1450-1147163248.

19. Dalen JE. Thrombolytics decrease mortality in elderly patients with unstable pulmonary embolism. Am J Med. 2013;126(4):278-79. doi:10.1016/j.amjmed.2012.11.009.

20. Berns SA, Shmidt EA, Nagirnyak OA, et al. Pulmonary Embolism: Women Are at Risk. Doctor.Ru. 2015;8-9:14-21. (In Russ.)

21. Vardugina NG, Vavilov VV, Ponomareva SY, et al. Clinic risk factors and peculiarities of development of pulmonary embolism in women over the age of 55 years. Modern problems of science and education. 2017;(6): http://science-education.ru/ru/article/ view?id=27261. (In Russ.) http://science-education.ru/ru/article/view?id=27261 (27 сентябрь 2019).